AliveCor detects AFib more frequently than routine care, study shows

SAN FRANCISCO – AliveCor Kardia mobile electrocardiogram diagnosed nearly four times as many cases of atrial fibrillation than traditional screening, according to a recent study published in the American Heart Association’s Circulation Journal. Researchers studied 1,000 patients age 65 and older with increased risk of stroke and randomly assigned them to either the AliveCor Kardia device or routine care over 12 months. The results showed that 19 patients in the group using the AliveCor monitor were diagnosed with AFib versus five in the group receiving routine care. The researchers concluded that twice-weekly screening with a mobile ECG is significantly more likely to identify incident AFib than routine care over a 12-month period.